The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
SJD Pediatric Cancer Center Barcelona 2023
Invest for children is one of the founding donors of the creation of the SJD Pediatric Cancer Center Since its opening, more than 700 patients have already passed through the…
see project 
